emetine has been researched along with sirolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
| Fabbro, D; Ferrari, S; Frost, V; Mercep, L; Meyer, T; Morley, SJ | 1 |
| Connor, SA; Hoeffer, CA; Klann, E; Nguyen, PV | 1 |
3 other study(ies) available for emetine and sirolimus
| Article | Year |
|---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
The phosphodiesterase inhibitor SQ 20006 selectively blocks mitogen activation of p70S6k and transition to S phase of the cell division cycle without affecting the steady state phosphorylation of eIF-4E.
Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle; Cell Division; Cell Line; Cyclic AMP; Emetine; Enzyme Activation; Eukaryotic Initiation Factor-4E; Humans; Hydroxyurea; Immunosuppressive Agents; Kinetics; Mice; Mitogen-Activated Protein Kinase 1; Mitogens; Nicotinic Acids; Peptide Initiation Factors; Phosphodiesterase Inhibitors; Phosphorylation; Polyenes; Polyribosomes; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Reticulocytes; Ribosomal Protein S6 Kinases; S Phase; Sirolimus | 1995 |
Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
Topics: Adrenergic beta-Agonists; Animals; Bicuculline; Biophysics; Dose-Response Relationship, Drug; Electric Stimulation; Emetine; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Flavonoids; Fragile X Mental Retardation Protein; GABA-A Receptor Antagonists; Hippocampus; Immunosuppressive Agents; In Vitro Techniques; Isoproterenol; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Neurons; Patch-Clamp Techniques; Pyridines; rap GTP-Binding Proteins; Sirolimus; Time Factors | 2011 |